Concepedia
Statistics
Publications
29
Citations
642
H-Index
15
Active since
1992
Affiliations
University of California, Davis(Current)
University of California Davis Medical Center
University of Turku
Merck KGaA, Darmstadt (Germany)
The University of Texas at San Antonio Health Science Center
Gregory T. Wurz is an author at University of California, Davis specializing in pharmacology, medicine, and oncology.
Publications per year
1992–2022
In vitro and in vivo biologic effects of Ospemifene (FC-1271a) in breast cancer
Tracy L. Taras, Gregory T. Wurz, Michael W. DeGregorio · The Journal of Steroid Biochemistry and Molecular Biology · 2001 · 83 citations
Medicine, Oncology, Pharmacology +13
Selective estrogen receptor modulators inhibit growth and progression of premalignant lesions in a mouse model of ductal carcinoma in situ
Ruria Namba, Lawrence J.T. Young, Jeannie E. Maglione et al. · Breast Cancer Research · 2005 · 61 citations · Full text
Medicine, Endocrinology, Oncology +17
Ospemifene inhibits the growth of dimethylbenzanthracene-induced mammary tumors in Sencar mice
Gregory T. Wurz, Karla C. Read, Cristina Marchisano-Karpman et al. · The Journal of Steroid Biochemistry and Molecular Biology · 2005 · 53 citations
Medicine, Oncology, Pharmacology +12
Pharmacokinetics of (deaminohydroxy)toremifene in humans: a new, selective estrogen-receptor modulator
Michael W. DeGregorio, Gregory T. Wurz, Tracy L. Taras et al. · European Journal of Clinical Pharmacology · 2000 · 44 citations
Medicine, Pharmacokinetics, Pharmacology +9
Genotoxic effects of the novel mixed antiestrogen FC-1271a in comparison to tamoxifen and toremifene
Utha Hellmann‐Blumberg, Tracy L. Taras, Gregory T. Wurz et al. · Breast Cancer Research and Treatment · 2000 · 37 citations
Pharmacy, Oncology, Toxicology +12
1–5 of 29